Jane Street’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.9M Buy
179,000
+62,800
+54% +$18.7M 0.01% 1021
2025
Q4
$31.7M Sell
116,200
-22,700
-16% -$6.17M ﹤0.01% 1224
2025
Q3
$37.5M Sell
138,900
-4,400
-3% -$1.2M 0.01% 1111
2025
Q2
$39.5M Buy
143,300
+12,900
+10% +$3.51M 0.01% 929
2025
Q1
$34.6M Buy
130,400
+50,100
+62% +$12.4M 0.01% 900
2024
Q4
$18.6M Sell
80,300
-263,000
-77% -$60.5M ﹤0.01% 1311
2024
Q3
$75.7M Buy
343,300
+141,800
+70% +$29.3M 0.02% 498
2024
Q2
$39.6M Buy
201,500
+135,300
+204% +$28M 0.01% 828
2024
Q1
$14.3M Buy
66,200
+5,800
+10% +$1.22M ﹤0.01% 1482
2023
Q4
$12.7M Sell
60,400
-29,500
-33% -$6.29M ﹤0.01% 1694
2023
Q3
$18M Buy
89,900
+16,900
+23% +$3.36M 0.01% 1190
2023
Q2
$13.5M Sell
73,000
-89,400
-55% -$16.5M ﹤0.01% 1594
2023
Q1
$31.1M Buy
162,400
+40,600
+33% +$7.34M 0.01% 734
2022
Q4
$20.5M Sell
121,800
-100
-0.1% -$17.4K 0.01% 989
2022
Q3
$21.6M Sell
121,900
-49,900
-29% -$9.86M 0.01% 1005
2022
Q2
$35.2M Sell
171,800
-9,700
-5% -$2.06M 0.01% 738
2022
Q1
$43.2M Buy
181,500
+55,100
+44% +$12.9M 0.01% 751
2021
Q4
$28.9M Sell
126,400
-28,700
-19% -$6.31M 0.01% 942
2021
Q3
$30M Buy
155,100
+37,400
+32% +$7.58M 0.01% 861
2021
Q2
$25M Sell
117,700
-39,900
-25% -$8.42M 0.01% 920
2021
Q1
$32.2M Sell
157,600
-145,100
-48% -$28.6M 0.02% 664
2020
Q4
$55.1M Buy
302,700
+50,900
+20% +$8.66M 0.03% 426
2020
Q3
$42.1M Buy
251,800
+87,600
+53% +$14.8M 0.03% 456
2020
Q2
$26.7M Buy
164,200
+66,800
+69% +$12M 0.02% 611
2020
Q1
$16.8M Buy
97,400
+59,700
+158% +$11.9M 0.02% 523
2019
Q4
$7.57M Buy
37,700
+19,100
+103% +$3.92M 0.01% 797
2019
Q3
$3.93M Buy
18,600
+2,400
+15% +$501K 0.01% 1171
2019
Q2
$3.15M Sell
16,200
-8,800
-35% -$1.62M 0.01% 1429
2019
Q1
$4.12M Sell
25,000
-8,200
-25% -$1.45M 0.01% 1302
2018
Q4
$6.25M Buy
33,200
+23,100
+229% +$4.27M 0.01% 803
2018
Q3
$1.72M Sell
10,100
-13,100
-56% -$2.21M ﹤0.01% 2072
2018
Q2
$3.8M Sell
23,200
-15,500
-40% -$2.53M 0.01% 1284
2018
Q1
$6.26M Sell
38,700
-25,700
-40% -$4.09M 0.02% 812
2017
Q4
$9.41M Sell
64,400
-49,000
-43% -$6.98M 0.03% 536
2017
Q3
$15.4M Buy
113,400
+92,000
+430% +$11.6M 0.05% 355
2017
Q2
$2.68M Buy
21,400
+15,100
+240% +$1.81M 0.01% 1223
2017
Q1
$748K Sell
6,300
-80,300
-93% -$9.66M ﹤0.01% 2425
2016
Q4
$9.99M Buy
86,600
+80,300
+1,275% +$8.94M 0.04% 350
2016
Q3
$658K Sell
6,300
-20,800
-77% -$2.17M ﹤0.01% 2461
2016
Q2
$2.64M Sell
27,100
-10,300
-28% -$973K 0.01% 1026
2016
Q1
$3.59M Buy
37,400
+12,900
+53% +$1.17M 0.02% 742
2015
Q4
$2.22M Buy
+24,500
New +$2.31M 0.01% 974
2015
Q3
Sell
-17,900
Closed -$1.67M 3616
2015
Q2
$1.67M Buy
+17,900
New +$1.67M 0.01% 1126

Other funds holding CME

Jane Street's CME Position: Q1 2026 in Review

Jane Street increased its CME Group (CME) stake by 541% in Q1 2026, buying an estimated $84.5M and bringing the position to 336,922 shares worth $99.5M. The position accounts for 0.01% of the portfolio, ranked #644.

Jane Street first reported a position in CME in Q3 2013 and has held it in 49 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Jane Street held 336,922 shares of CME Group worth $99.5M as of Q1 2026.
  • Jane Street bought 284,334 CME Group shares in Q1 2026, an estimated $84.5M.
  • CME Group made up 0.01% of Jane Street's portfolio in Q1 2026, its #644 holding.
  • Jane Street first reported a position in CME Group in Q3 2013 and has held it in 49 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.